Status | Study |
Recruiting |
Study Name: Stem Cell Ophthalmology Treatment Study Condition: Retinal Disease Macular Degeneration Hereditary Date: 2013-08-08 Interventions: Procedure: RB (Retrobulbar) Re |
Active, not recruiting |
Study Name: Visual and Functional Assessment in Low Vision Patients Condition: Retinitis Pigmentosa Age-related Macular Degeneration Opti Date: 2013-06-10 |
Active, not recruiting |
Study Name: Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy Condition: Retinitis Pigmentosa Cone Rod Dystrophy Choroideremia Date: 2013-05-15 Interventions: Device: Intelligent Retinal Implant System |
Terminated |
Study Name: Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease Condition: Stargardt Disease Date: 2012-08-23 |
Recruiting |
Study Name: Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases Condition: Retinal Dystrophies Age-related Macular Degeneration Date: 2012-03-02 |
Completed |
Study Name: Clinical Gene Therapy Protocol for the Treatment of Retinal Dystrophy Caused by Defects in RPE65 Condition: Leber Congenital Amaurosis Date: 2011-11-24 Interventions: Drug: rAAV2/4.hRPE65 One injection in on eye |
Completed |
Study Name: Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa Condition: Retinitis Pigmentosa Retinal Diseases Eye Diseases Date: 2011-05-03 Interventions: Drug: Valproic Acid One 500mg tablet by mouth daily |
Recruiting |
Study Name: The Natural History of Mucolipidosis Type IV Condition: Mucolipidosis Type IV Date: 2010-02-10 |
Completed |
Study Name: Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients Condition: Retinitis Pigmentosa Retinal Degeneration Date: 2009-11-26 Interventions: Device: Device name: "Retina Implant model Alpha". Surgical implantation of medical device into eye |
Active, not recruiting |
Study Name: Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis Condition: Inherited Retinal Dystrophy Due to RPE65 Mutations Leber Congen Date: 2009-10-21 Interventions: Biological: AAV2-hRPE65v2 Subretinal administration of gene therapy vector AAV2-hRPE65v2 (1.5E11 vector |